Your browser doesn't support javascript.
loading
What is a response in randomised controlled trials in giant cell arteritis?
Dejaco, Christian; Ramiro, Sofia; Touma, Zahi; Bond, Milena; Soowamber, Medha; Sanchez-Alvarez, Catalina; Langford, Carol A.
Affiliation
  • Dejaco C; Department of Rheumatology, Medical University of Graz, Graz, Austria christian.dejaco@gmx.net.
  • Ramiro S; Department of Rheumatology, Brunico Hospital, Teaching Hospital of the Paracelsius Medical University, Brunico, Italy.
  • Touma Z; Rheumatology, Leiden University Medical Center, Leiden, The Netherlands.
  • Bond M; Rheumatology, Zuyderland Medical Centre Heerlen, Heerlen, The Netherlands.
  • Soowamber M; Department of Rheumatology, Schroeder Arthritis Institute, Krembil Research Institute, University Health Network, Toronto, Ontario, Canada.
  • Sanchez-Alvarez C; Department of Rheumatology, Brunico Hospital, Teaching Hospital of the Paracelsius Medical University, Brunico, Italy.
  • Langford CA; Rheumatology, Mount Sinai Hospital, Toronto, Ontario, Canada.
Ann Rheum Dis ; 82(7): 897-900, 2023 07.
Article in En | MEDLINE | ID: mdl-36801812
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Giant Cell Arteritis Type of study: Clinical_trials Aspects: Patient_preference Limits: Humans Language: En Journal: Ann Rheum Dis Year: 2023 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Giant Cell Arteritis Type of study: Clinical_trials Aspects: Patient_preference Limits: Humans Language: En Journal: Ann Rheum Dis Year: 2023 Document type: Article Affiliation country: Country of publication: